APOE and cerebral amyloid angiopathy in the elderly
APOE and cerebral amyloid angiopathy in the elderly
Over 30% of normal elderly people have cerebral amyloid angiopathy (CAA). Possession of APOE [varepsilon]4 is associated with increased prevalence and severity of CAA in Alzheimer's disease (AD) and in cerebral haemorrhage. We examined CAA in relation to APOE genotype in brains from 152 people aged 60-102 years, without AD or cerebral haemorrhage. Prevalence of CAA increased with age (p = 0.003). CAA was not associated with APOE genotype. The frequency of [varepsilon]4 showed a significant negative association with age (p = 0.016). Age at death was significantly lower in those with than without [varepsilon]4 (p = 0.028). Possession of [varepsilon]4 does not by itself confer an increased risk of CAA but may be associated with reduced longevity even in the absence of AD or cerebral haemorrhage.
1535-1536
Love, Seth
c8c00a86-ecf8-4f61-8377-254305bdbc02
Nicoll, James A.R.
88c0685f-000e-4eb7-8f72-f36b4985e8ed
Hughes, Anthony
395ae4ef-2bc5-413d-842b-17f5d28cd2c9
Wilcock, Gordon K.
caae0bad-4a40-4ef5-9c19-ea4cb741a0e0
2003
Love, Seth
c8c00a86-ecf8-4f61-8377-254305bdbc02
Nicoll, James A.R.
88c0685f-000e-4eb7-8f72-f36b4985e8ed
Hughes, Anthony
395ae4ef-2bc5-413d-842b-17f5d28cd2c9
Wilcock, Gordon K.
caae0bad-4a40-4ef5-9c19-ea4cb741a0e0
Love, Seth, Nicoll, James A.R., Hughes, Anthony and Wilcock, Gordon K.
(2003)
APOE and cerebral amyloid angiopathy in the elderly.
NeuroReport, 14 (11), .
Abstract
Over 30% of normal elderly people have cerebral amyloid angiopathy (CAA). Possession of APOE [varepsilon]4 is associated with increased prevalence and severity of CAA in Alzheimer's disease (AD) and in cerebral haemorrhage. We examined CAA in relation to APOE genotype in brains from 152 people aged 60-102 years, without AD or cerebral haemorrhage. Prevalence of CAA increased with age (p = 0.003). CAA was not associated with APOE genotype. The frequency of [varepsilon]4 showed a significant negative association with age (p = 0.016). Age at death was significantly lower in those with than without [varepsilon]4 (p = 0.028). Possession of [varepsilon]4 does not by itself confer an increased risk of CAA but may be associated with reduced longevity even in the absence of AD or cerebral haemorrhage.
This record has no associated files available for download.
More information
Published date: 2003
Identifiers
Local EPrints ID: 27642
URI: http://eprints.soton.ac.uk/id/eprint/27642
PURE UUID: 17b38330-dd0a-40f6-8c7c-718ed7cd201c
Catalogue record
Date deposited: 28 Apr 2006
Last modified: 09 Jan 2022 03:09
Export record
Contributors
Author:
Seth Love
Author:
Anthony Hughes
Author:
Gordon K. Wilcock
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics